Novavax Inc (NASDAQ:NVAX)
| 113.51 Delayed Data As of Sep 25 |  +11.07 / +10.81%Today’s Change | 3.54 Today|||52-Week Range 189.40 | +2,752.01% Year-to-Date |
Latest NVAX News | Press Releases
Today’s Trading
| Previous close | 102.44 |
| Today’s open | 107.52 |
| Day’s range | 106.00 - 117.19 |
| Volume | 215,201 |
| Average volume (3 months) | 7,869,325 |
| Market cap | $6.6B |
Data as of 4:37pm ET, 09/25/2020
Growth & Valuation
| Earnings growth (last year) | +44.90% |
| Earnings growth (this year) | +265.07% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -45.57% |
| P/E ratio | NM |
| Price/Sales | 5.14 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | +2.22 | +2.88% |
| XLRNAcceleron Pharma Inc | +3.03 | +2.88% |
| MNTAMomenta Pharmaceutic... | 0.00 | 0.00% |
| CRSPCRISPR Therapeutics ... | +0.80 | +0.96% |
Data as of 4:00pm ET, 09/25/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | $1.73 |
| Annual revenue (last year) | $18.7M |
| Annual profit (last year) | -$132.7M |
| Net profit margin | -711.04% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
